del Mar MM, Carvajal CM

Language: Spanish
References: 24
Page: 571-574
PDF size: 410.01 Kb.

ABSTRACT

Congenital malformations affecting a Global Level 1 in 33 infants, corresponding to 270,000 cases annually. Of the 10.6 % cause heart defects and postnatal deaths of 1-1.8 them of newborns die alive in the early days for critical heart disease, heart disease defined as those that can cause death in the prime of life month newborn, requiring intervention by the firts year. These dependent child heart of the ductus arteriosus to live for which it is vital importance of detecting these early malformations paragraph sequelae and mortality avoid delay in treatment of heart these criticisms worse prognosis for this reason, the establishment of critical heart disease screening proposed by pulse oximetry, noninvasive method, inexpensive and early detection useful paragraph.

REFERENCES

1. Alonso Clara . Detección precoz de cardiopatías congénitas mediante pulsioximetría. Servicio de neonatología Hospital Universitario 12 de Octubre. Madrid. Actualización Diciembre 2012.

2. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26:832-5.

3. Barboza-Arguello MP, Benavides- Lara A, Umaña L, Vargas-Leitón B. Mortalidad infantil por defectos congénitos en Costa Rica, 1981– 2010. Rev Panam Salud Pública. 2013;34(5):304–11.

4. Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011;378:785-94. D.O.I.: 10.1016/ S0140-6736(11)60753-8.

5. Ewer Andrew.K, Evidence for CCHD screening and its practical application using pulse oximetry. Elservier

6. Granelli De-Wahi A y col. Screening for duct –dependent congenital Heart disease with pulse oximetry: a critical evaluation of strategies to maximize sensitivity. Acta Pediatr 2005:94:1590-6.

7. Guidelines for Pulse Oximetry Screening for Critical Congenital Heart Disease. Michigan department of community health.

8. INEChttp://www.inec.go.cr/Web/ Home/GeneradorPagina.aspx

9. Mahle William T., Newburger Jane W., G. Matherne Paul, Smith Frank C., Hoke Tracey R., Koppel Robert, Samuel S. Gidding, Robert H. Beekman III and Scott D. Grosse .Role of Pulse Oximetry in Examining Newborns for Congenital Heart Disease: A Scientific Statement From the American Heart Association and American Academy of Pediatrics. Circulation.2009;120:447-458; originally published online July 6, 2009.

10. Peterson C, Ailes E, Riehle- Colarusso T, Oster ME, Olney RS, Cassell CH, et al. Late detection of critical congenital heart disease among US infants. Estimation of the potential impact of proposed universal screening using pulse oximetry. JAMA Pediatr 2014; 168(4): 361–370.

11. Sebelius K. Secretary of Health and Human Services recommendation for pulse oximetry screening. Washington, DC: Department of Health and Human Services, 2011: http://www. hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders/ recommendations/correspondence/ cyanoticheartsecre09212011.pdf

12. Zhao Q, Ma X, Ge X, Liu F, Yan W, Wu L, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 2014; [Epub ahead of print], published online April 23: doi: 10.1016/ S0140-6736(14)60198-7

13. Alonso Clara . Detección precoz de cardiopatías congénitas mediante pulsioximetría. Servicio de neonatología Hospital Universitario 12 de Octubre. Madrid. Actualización Diciembre 2012.

14. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26:832-5.

15. Barboza-Arguello MP, Benavides- Lara A, Umaña L, Vargas-Leitón B. Mortalidad infantil por defectos congénitos en Costa Rica, 1981– 2010. Rev Panam Salud Pública. 2013;34(5):304–11.

16. Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011;378:785-94. D.O.I.: 10.1016/ S0140-6736(11)60753-8.

17. Ewer Andrew.K, Evidence for CCHD screening and its practical application using pulse oximetry. Elservier

18. Granelli De-Wahi A y col. Screening for duct –dependent congenital Heart disease with pulse oximetry: a critical evaluation of strategies to maximize sensitivity. Acta Pediatr 2005:94:1590-6.

19. Guidelines for Pulse Oximetry Screening for Critical Congenital Heart Disease. Michigan department of community health.

20. INEChttp://www.inec.go.cr/Web/ Home/GeneradorPagina.aspx

21. Mahle William T., Newburger Jane W., G. Matherne Paul, Smith Frank C., Hoke Tracey R., Koppel Robert, Samuel S. Gidding, Robert H. Beekman III and Scott D. Grosse .Role of Pulse Oximetry in Examining Newborns for Congenital Heart Disease: A Scientific Statement From the American Heart Association and American Academy of Pediatrics. Circulation.2009;120:447-458; originally published online July 6, 2009.

22. Peterson C, Ailes E, Riehle- Colarusso T, Oster ME, Olney RS, Cassell CH, et al. Late detection of critical congenital heart disease among US infants. Estimation of the potential impact of proposed universal screening using pulse oximetry. JAMA Pediatr 2014; 168(4): 361–370.

23. Sebelius K. Secretary of Health and Human Services recommendation for pulse oximetry screening. Washington, DC: Department of Health and Human Services, 2011: http://www. hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders/ recommendations/correspondence/ cyanoticheartsecre09212011.pdf

24. Zhao Q, Ma X, Ge X, Liu F, Yan W, Wu L, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 2014; [Epub ahead of print], published online April 23: doi: 10.1016/ S0140-6736(14)60198-7